From Sept 1, 2022, we restarted Ikeda Lab at FBS, Osaka Univ.
News
Our lab has moved to Osaka Univ.
We moved to Osaka Univ and will restart our research there.
We all thank people at the MIB, Kyushu Univ. and hope for the best.
池田研は大阪大学大学院生命機能研究科に引っ越ししました。
生医研の皆様にはこれまでのサポートに感謝いたします。ありがとうございました。
We are moving to Osaka University later this year!
The Ikeda Lab is moving to the Graduate School of Frontier Biosciences, Osaka University later this year. Here is a link to a new affiliation! (Fumiyo started a cross appointment in April.)
New review article on “LUBAC and disease” is out!
Fumiyo wrote a short review article with Fuminori Tokunaga (Osaka City Univ) describing how defect of linear ubiquitination induced by LUBAC may correlate with human diseases such as autoimmunes and neurodegenerative diseases. We also disucssed potential applications of LUBAC inhibitors.
Tokunaga F, Ikeda F. Linear ubiquitination in immune and neurodegenerative
diseases, and beyond. Biochem Soc Trans. 2022 Mar 28:BST20211078. doi:
10.1042/BST20211078. Epub ahead of print. PMID: 35343567.
New grants approved for Kota Yanagitani and Fumiyo Ikeda
柳谷耕太が2021年度JST創発的研究支援事業への採択が決定しました。
https://www.jst.go.jp/souhatsu/call/sel21.html
池田史代が2021年度武田報彰医学研究助成に採択されました。
https://www.takeda-sci.or.jp/business/doc/2021_list.pdf
お祝いのランチ(カメラマン:清田さん)